News

20 November 2019
Baylis Medical announced today the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution is the world’s first all-in-one left-heart access device featuring an atraumatic RF-tipped wire, which acts as both puncture device and exchange rail. The puncture wire features Baylis’ signature RF puncture technology, which facilitates controlled and precise transseptal procedures.
Press Release
05 November 2019
A randomized controlled trial has found that use of Baylis Medical’s NRG® Transseptal Needle results in shorter time in achieving transseptal access, less transseptal attempts, and reduced exposure to radiation, compared to use of a conventional transseptal needle.
Press Release
18 September 2019
Baylis Medical announced today key activities that will be featured at Transcatheter Cardiovascular Therapeutics (TCT) 2019, the Cardiovascular Research Foundation’s 31st annual conference and premier interventional cardiovascular medicine educational meeting, in San Francisco, CA from September 25-29.
Press Release
19 June 2019
A cost-effectiveness analysis completed by the University of California, San Francisco (UCSF) and Baylis Medical has shown that use of Baylis’ RF transseptal needle results in cost savings per procedure, compared to use of a mechanical transseptal needle.
Press Release
07 March 2019
For the second year in a row, Baylis Medical has won the Canada’s Best Managed Companies designation.
Press Release
30 January 2019
Baylis Medical is pleased to announce that seasoned marketing executive Gloria Yee has joined Baylis as its Vice President of Marketing. In her role, Gloria will be instrumental in expanding the company’s global commercialization strategy.
Press Release

Media Contact

media@baylismedical.com